Warning
MYLAN PHARMACEUTICALS INC Recalls Mycophenolate Mofetil for Injection USP
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0734-2026Drug / Pharmaceutical
MYLAN PHARMACEUTICALS INC Recalls Mycophenolate Mofetil for Injection USP
MYLAN PHARMACEUTICALS INC · Class II — Moderate Risk
Product Description
Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00.
Reason for Recall
Presence of precipitate
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
USA Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
MYLAN PHARMACEUTICALS INC has recalled a pharmaceutical product that the FDA classified as Class II affecting 5688 vials. The recall was initiated on July 2, 2026. Presence of precipitate. It was distributed in USA Nationwide. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.
Sources: FDA openFDA Enforcement Database
This recall appears in: Other Injury Hazards.